The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Sara.Al-Badran@glasgow.ac.uk
pronouns:
She/her/hers
Pennel, K. A.F. et al. (2024) JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental and Clinical Cancer Research, 43, 64. (doi: 10.1186/s13046-024-02958-4)
Shamis, S. A. K., Savioli, F., Ammar, A. , Al-Badran, S. S.F., Hatthakarnkul, P. , Leslie, H. , Mallon, E., Jamieson, N. B. , McMillan, D. C. and Edwards, J. (2024) Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay. Histology and Histopathology: Cellular and Molecular Biology, 39, pp. 177-200. (doi: 10.14670/HH-18-655) (PMID:37681672)
Edwards, J. et al. (2023) Association of Wnt Signalling With Metachronous Colonic Polyp Risk. 2023 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 19-21 Jan 2023. p. 232. (doi: 10.1200/JCO.2023.41.4_suppl.232)
Johnstone, M. S., Al-Badran, S. S.F., Stoops, R., Hay, J., Jawny, J., Lynch, G., McSorley, S. T. and Edwards, J. (2023) Immunohistochemical Assessment of COX2, P53, and Beta-catenin Expression to Predict Metachronous Lesion Development Following Polypectomy. 2023 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 19-21 Jan 2023. p. 234. (doi: 10.1200/JCO.2023.41.4_suppl.234)
Patel, M., McAllister, M., Nagaraju, R., Al Badran, S. S. F., Edwards, J. , McBain, A. J., Barriuso, J. and Aziz, O. (2022) The intestinal microbiota in colorectal cancer metastasis - Passive observer or key player? Critical Reviews in Oncology/Hematology, 180, 103856. (doi: 10.1016/j.critrevonc.2022.103856) (PMID:36257533)
Al-Badran, S. S.F. et al. (2021) Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer. Journal of Pathology: Clinical Research, 7(2), pp. 121-134. (doi: 10.1002/cjp2.193) (PMID:33338327)
Pennel, K. A.F. et al. (2024) JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. Journal of Experimental and Clinical Cancer Research, 43, 64. (doi: 10.1186/s13046-024-02958-4)
Shamis, S. A. K., Savioli, F., Ammar, A. , Al-Badran, S. S.F., Hatthakarnkul, P. , Leslie, H. , Mallon, E., Jamieson, N. B. , McMillan, D. C. and Edwards, J. (2024) Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay. Histology and Histopathology: Cellular and Molecular Biology, 39, pp. 177-200. (doi: 10.14670/HH-18-655) (PMID:37681672)
Patel, M., McAllister, M., Nagaraju, R., Al Badran, S. S. F., Edwards, J. , McBain, A. J., Barriuso, J. and Aziz, O. (2022) The intestinal microbiota in colorectal cancer metastasis - Passive observer or key player? Critical Reviews in Oncology/Hematology, 180, 103856. (doi: 10.1016/j.critrevonc.2022.103856) (PMID:36257533)
Al-Badran, S. S.F. et al. (2021) Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer. Journal of Pathology: Clinical Research, 7(2), pp. 121-134. (doi: 10.1002/cjp2.193) (PMID:33338327)
Edwards, J. et al. (2023) Association of Wnt Signalling With Metachronous Colonic Polyp Risk. 2023 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 19-21 Jan 2023. p. 232. (doi: 10.1200/JCO.2023.41.4_suppl.232)
Johnstone, M. S., Al-Badran, S. S.F., Stoops, R., Hay, J., Jawny, J., Lynch, G., McSorley, S. T. and Edwards, J. (2023) Immunohistochemical Assessment of COX2, P53, and Beta-catenin Expression to Predict Metachronous Lesion Development Following Polypectomy. 2023 ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, USA, 19-21 Jan 2023. p. 234. (doi: 10.1200/JCO.2023.41.4_suppl.234)